Skip to content

GP CLASSICS: value indication

Roughly what is an SME worth on what it filed? A range from its adjusted equity and its earnings, with your own assumptions, recalculated as you go.

Value indication

GP CLASSICS

BE 0728.462.377
NACE 47.811, Retail sale of cars and light vans (up to 3.5 tonnes)
latest balance sheet 31-12-2024indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€43,917 to €53,167

Midpoint €47,771 · 50% capitalised earnings, 50% adjusted equity

Adjusted equity €41,584
Capitalised earnings €46,250 to €64,750
Indication €43,917 to €53,167

Your assumptions

Capitalised earnings
%

The return a buyer expects on the money put in. Higher for more risk. The range also computes with 2 points more and less.

Adjust the equity
Blend
50%
Optional: your own multiple

Checked holds no market prices, so it suggests no multiple. If you have one from a transaction or a study, the tool applies it to the filed EBITDA less the net financial debt.

Adjusted equity

balance sheet 31-12-2024
Equity (10/15)
€41,584
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€41,584

Capitalised earnings

net result for the year (9904)
2024
€420
2023
€12,659
2022
€6,348
2021
-€10,765
2020
€25,183
Average result
€6,475
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€46,250 / €53,958 / €64,750

What this indication leaves out

  • Market prices and comparable transactions: Checked does not hold them.
  • Anything after the latest accounts, and items off the balance sheet (guarantees, leases, disputes).
  • The real value of buildings, stock and receivables: enter your own revaluation or adjustment.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale.

For a valuation to decide on: a company auditor or a certified accountant.

Source: filed annual accounts (NBB), latest balance sheet at 31 December 2024. Prepared on 29 September 2026 via checked.be. Indication, not a valuation or advice.